Position in TNGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,966,918
-$14,942,127 QoQ
Shares Held
510,778
-65.4% QoQ
Ownership
0.303%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 247 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. TNGX ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in TNGX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,966,918 | 510,778 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $30,909,045 | 1,477,488 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,597,093 | 1,421,794 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $2,115,057 | 251,793 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,737,256 | 534,621 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $343,207 | 250,519 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $989,012 | 320,070 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,633,221 | 341,977 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,088,102 | 243,369 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,425,377 | 179,519 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,419,727 | 143,407 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,176,826 | 193,324 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $179,922 | 54,194 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $298,582 | 75,591 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $209,660 | 28,919 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $83,858 | 23,166 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $83,494 | 18,432 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $119,118 | 15,715 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $96,675 | 8,837 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $23,881 | 1,847 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||